STAB News and Press, Statera Biopharma Inc. From 10/06/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is seeing gains on Thursday as investors react to news of it expanding its product portfolio pipeline . That expansion has the comp...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Statera Biopharma (NASDAQ: STAB ) stock is rising higher on Thursday as the company holds a meeting with The Nasdaq Stock Market’s Nasdaq Hearings Panel. The me...

Statera Biopharma ( NASDAQ: STAB ) provided an update on its request for a hearing before the Nasdaq Hearings Panel caused by delayed filing of its form 10-Q for the June quarter with the U.S. SEC in a timely manner. STAB had previously said that it had got ...

FORT COLLINS, CO / ACCESSWIRE / September 9, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced - as disclosed via the C...

NEW YORK, Aug. 26, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that trading resumed in Statera Biopharma, Inc. (Nasdaq: STAB) today, August 26, 2022 at 7:10 a.m. Eastern Time. Trading in the company’s stock was halted on August 25, 2022 at 11:...

Statera Biopharma ( NASDAQ: STAB ) on Thursday said it had got an expected additional notice of non-compliance from Nasdaq due to the company's failure to file its form 10-Q for the June quarter with the U.S. SEC in a timely manner. STAB had previously said that it had got...

FORT COLLINS, CO / ACCESSWIRE / August 25, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that, as expected, the Com...

NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that trading was halted today in Statera Biopharma, Inc. (Nasdaq: STAB) at 11:01:52 A.M. Eastern Time for "additional information requested" from the company at a last sale price of $0.21...

FORT COLLINS, Colo., June 14, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today...

Statera Biopharma (NASDAQ:STAB) said on Monday it had received a letter from the Nasdaq on May 18 stating that it had failed to file its quarterly report on form 10-Q for the first quarter and therefore had not complied with Nasdaq listing rule. "Statera is searching to identify a new indepen...